RIL
Rothschild Investment LLC Portfolio holdings
AUM
$1.6B
1-Year Return
17.99%
This Quarter Return
+9.71%
1 Year Return
+17.99%
3 Year Return
+73.94%
5 Year Return
+135.61%
10 Year Return
+254.21%
AUM
$1.6B
AUM Growth
+$101M
(+6.8%)
Cap. Flow
-$4.27M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
23.06%
Holding
3,233
New
209
Increased
1,380
Reduced
863
Closed
217
Top Buys
Top Sells
| 1 |
Novo Nordisk
NVO
|
+$7.27M |
| 2 |
Kenvue
KVUE
|
+$4.89M |
| 3 |
FPF
First Trust Intermediate Duration Preferred & Income Fund
FPF
|
+$3.13M |
| 4 |
Nuveen Preferred & Income Opportunities Fund
JPC
|
+$2.87M |
| 5 |
Apple
AAPL
|
+$2.73M |
Sector Composition
| 1 | Technology | 18.15% |
| 2 | Financials | 13.7% |
| 3 | Industrials | 9.06% |
| 4 | Healthcare | 7.79% |
| 5 | Communication Services | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Peabody Energy
BTU
$2.24B
| $3.02K | ﹤0.01% |
225
+110
| +96% | +$1.48K |
|
1777
Topgolf Callaway Brands
MODG
$1.76B
| $3.02K | ﹤0.01% |
375
+250
| +200% | +$2.01K |
|
1778
Perella Weinberg Partners
PWP
$1.43B
| $3.01K | ﹤0.01% |
155
+135
| +675% | +$2.62K |
|
|
NXRT
1779
NexPoint Residential Trust
NXRT
$858M
| $3K | ﹤0.01% |
90
+45
| +100% | +$1.5K |
|
1780
Agios Pharmaceuticals
AGIO
$2.14B
| $2.99K | ﹤0.01% |
90
-20
| -18% | -$665 |
|
1781
Flywire
FLYW
$1.63B
| $2.98K | ﹤0.01% |
255
+175
| +219% | +$2.05K |
|
1782
Brunswick
BC
$4.26B
| $2.98K | ﹤0.01% |
54
+38
| +238% | +$2.1K |
|
1783
Wolverine World Wide
WWW
$2.48B
| $2.98K | ﹤0.01% |
165
+25
| +18% | +$452 |
|
1784
Skyworks Solutions
SWKS
$11.1B
| $2.98K | ﹤0.01% |
40
-15
| -27% | -$1.12K |
|
1785
Warrior Met Coal
HCC
$3.04B
| $2.98K | ﹤0.01% |
65
-30
| -32% | -$1.38K |
|
1786
Northwest Natural Holdings
NWN
$1.73B
| $2.98K | ﹤0.01% |
75
-5
| -6% | -$199 |
|
1787
Washington Trust Bancorp
WASH
$573M
| $2.97K | ﹤0.01% |
105
+20
| +24% | +$566 |
|
1788
NextNav
NN
$2.3B
| $2.96K | ﹤0.01% |
195
+50
| +34% | +$760 |
|
1789
Travere Therapeutics
TVTX
$2.09B
| $2.96K | ﹤0.01% |
200
+50
| +33% | +$740 |
|
1790
CAVA Group
CAVA
$7.38B
| $2.95K | ﹤0.01% |
35
| – | – |
|
1791
Ares Management
ARES
$40.1B
| $2.94K | ﹤0.01% |
17
-2
| -11% | -$346 |
|
1792
Innospec
IOSP
$2.05B
| $2.94K | ﹤0.01% |
35
+10
| +40% | +$841 |
|
1793
IMAX
IMAX
$1.74B
| $2.94K | ﹤0.01% |
105
+30
| +40% | +$839 |
|
1794
Capri Holdings
CPRI
$2.43B
| $2.92K | ﹤0.01% |
+165
| New | +$2.92K |
|
1795
Penske Automotive Group
PAG
$11.9B
| $2.92K | ﹤0.01% |
17
+1
| +6% | +$172 |
|
1796
CRISPR Therapeutics
CRSP
$5.12B
| $2.92K | ﹤0.01% |
60
| – | – |
|
1797
XPO
XPO
$15.3B
| $2.91K | ﹤0.01% |
23
+2
| +10% | +$253 |
|
|
AIV
1798
Aimco
AIV
$1.07B
| $2.9K | ﹤0.01% |
335
-65
| -16% | -$562 |
|
1799
CommScope
COMM
$3.61B
| $2.9K | ﹤0.01% |
350
-20
| -5% | -$166 |
|
1800
NextDecade
NEXT
$1.79B
| $2.9K | ﹤0.01% |
325
+105
| +48% | +$936 |
|